269 related articles for article (PubMed ID: 31465982)
1. NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies.
Liu P; Lu Z; Liu L; Li R; Liang Z; Shen M; Xu H; Ren D; Ji M; Yuan S; Shang D; Zhang Y; Liu H; Tu Z
Phytomedicine; 2019 Nov; 64():152925. PubMed ID: 31465982
[TBL] [Abstract][Full Text] [Related]
2. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways.
Platnich JM; Muruve DA
Arch Biochem Biophys; 2019 Jul; 670():4-14. PubMed ID: 30772258
[TBL] [Abstract][Full Text] [Related]
3. Role of NOD- like Receptors in Glioma Angiogenesis: Insights into future therapeutic interventions.
Saxena S; Jha S
Cytokine Growth Factor Rev; 2017 Apr; 34():15-26. PubMed ID: 28233643
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptors participate in carcinogenesis signaling pathways by directly regulating NOD-like receptors.
Fan W; Gao X; Ding C; Lv Y; Shen T; Ma G; Yan L; Song S
Biochem Biophys Res Commun; 2019 Apr; 511(2):468-475. PubMed ID: 30797557
[TBL] [Abstract][Full Text] [Related]
5. The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury.
Ge X; Li W; Huang S; Yin Z; Xu X; Chen F; Kong X; Wang H; Zhang J; Lei P
Brain Res; 2018 Oct; 1697():10-20. PubMed ID: 29886252
[TBL] [Abstract][Full Text] [Related]
6. NOD-like receptors in autoimmune diseases.
Chen L; Cao SQ; Lin ZM; He SJ; Zuo JP
Acta Pharmacol Sin; 2021 Nov; 42(11):1742-1756. PubMed ID: 33589796
[TBL] [Abstract][Full Text] [Related]
7. NOD-Like Receptors: Master Regulators of Inflammation and Cancer.
Saxena M; Yeretssian G
Front Immunol; 2014; 5():327. PubMed ID: 25071785
[TBL] [Abstract][Full Text] [Related]
8. Focus on negatively regulated NLRs in inflammation and cancer.
Wang J; He W; Li C; Ma Y; Liu M; Ye J; Sun L; Su J; Zhou L
Int Immunopharmacol; 2024 Jul; 136():112347. PubMed ID: 38820966
[TBL] [Abstract][Full Text] [Related]
9. NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers.
Zhou Y; Yu S; Zhang W
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833958
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
11. The inflammasome: an emerging therapeutic oncotarget for cancer prevention.
Zhiyu W; Wang N; Wang Q; Peng C; Zhang J; Liu P; Ou A; Zhong S; Cordero MD; Lin Y
Oncotarget; 2016 Aug; 7(31):50766-50780. PubMed ID: 27206676
[TBL] [Abstract][Full Text] [Related]
12. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
Tang C; Zhu G
Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
[TBL] [Abstract][Full Text] [Related]
13. Inflammasome as a promising therapeutic target for cancer.
Lee C; Do HTT; Her J; Kim Y; Seo D; Rhee I
Life Sci; 2019 Aug; 231():116593. PubMed ID: 31228512
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome and Cancer.
Wang Z; Wang N; Zheng Y; Wang S
Exp Suppl; 2018; 108():281-302. PubMed ID: 30536176
[TBL] [Abstract][Full Text] [Related]
15. Role of Inflammasomes in the Development of Gastrointestinal Diseases.
Kanak MA; Shindo Y; SaiKumar P; Naziruddin B
Exp Suppl; 2018; 108():235-268. PubMed ID: 30536174
[TBL] [Abstract][Full Text] [Related]
16. Insights into inflammasome and its research advances in cancer.
Cao X; Xu J
Tumori; 2019 Dec; 105(6):456-464. PubMed ID: 31407634
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components.
Liu R; Truax AD; Chen L; Hu P; Li Z; Chen J; Song C; Chen L; Ting JP
Oncotarget; 2015 Oct; 6(32):33456-69. PubMed ID: 26378020
[TBL] [Abstract][Full Text] [Related]
18. Structural Biology of NOD-Like Receptors.
Yang X; Lin G; Han Z; Chai J
Adv Exp Med Biol; 2019; 1172():119-141. PubMed ID: 31628654
[TBL] [Abstract][Full Text] [Related]
19. NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer.
Velloso FJ; Trombetta-Lima M; Anschau V; Sogayar MC; Correa RG
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30837326
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inflammasomes in cancer and targeted therapies.
Gu Q; Zou J; Zhou Y; Deng Q
Front Oncol; 2023; 13():1133013. PubMed ID: 37020871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
